The clinical relevance of thymic fluorodeoxyglucose uptake in pediatric patients after chemotherapy

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 6, 2004, Pages 831-836

  Kawano, Tsuyoshi ^a   Suzuki, Akiko ^a   Ishida, Amane ^a   Takahashi, Nobukazu ^a   Lee, Jin ^a   Tayama, Yoshifumi ^a   Oka, Takashi ^a   Yokota, Shumpei ^a   Inoue, Tomio ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Children; Lymphocytes; Positron emission tomography; Thymus

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 68; GERMANIUM; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ARTICLE; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DRUG UPTAKE; EWING SARCOMA; HEPATOBLASTOMA; HUMAN; INFANT; LEUKEMIA; LEUKOCYTE; LEUKOCYTE DIFFERENTIAL COUNT; LIPOBLASTOMA; LYMPHOMA; NEPHROBLASTOMA; NEUROBLASTOMA; POSITRON EMISSION TOMOGRAPHY; THYMUS; TREATMENT OUTCOME;

EID: 2942614831     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1466-4     Document Type: Article

References (22)

1. Kawabe J, Okamura T, Shakudo M, et al. Physiological FDG uptake in the palatine tonsils. Ann Nucl Med 2001; 15:297-300.
2. Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996; 26:308-314.
3. Engel H, Steinert H, Buck A, et al. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996; 37:441-446.
4. Patel PM, Alibazoglu H, Ali A, et al. Normal thymic uptake of FDG on PET imaging. Clin Nucl Med 1996; 21:772-775.
5. 18F-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med. 2001; 42:591-595.
6. Weinblatt ME, Zanzi I, Belakhlef A, et al. False-positive FDG-PET imaging of the thymus of a child with Hodgkin's disease. J Nucl Med 1997; 38:888-890.
7. Yoon SN, Park CH, Kim MK, et al. False-positive F-18 FDG gamma camera positron emission tomographic imaging resulting from inflammation of an anterior mediastinal mass in a patient with non-Hodgkin's lymphoma. Clin Nucl Med 2001; 26:461-462.
8. 18F]FDG in childhood lymphoma: clinical utility and impact on management. Eur J Nucl Med Mol Imaging 2002; 29:1155-1165.
9. Shin MS, Ho KJ. Diffuse thymic hyperplasia following chemotherapy for nodular sclerosing Hodgkin's disease. An immunologic rebound phenomenon? Cancer 1983; 51:30-33.
10. Choyke PL, Zeman RK, Gootenberg JE, et al. Thymic atrophy and regrowth in response to chemotherapy: CT evaluation. AJR 1987; 149:269-272.
11. Kissin CM, Husband JE, Nicholas D, et al. Benign thymic enlargement in adults after chemotherapy: CT demonstration. Radiology 1987; 163:67-70.
12. Bell BA, Esseltine DW, Azouz EM. Rebound thymic hyperplasia in a child with cancer. Med Pediatr Oncol 1984; 12:144-147.
13. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27:235-238.
14. Inoue T, Oriuchi N, Kunio M, et al. Accuracy of standardized uptake value(SUV) measured by simultaneous emission and transmission scanning in PET oncology. Nucl Med Commun 1999; 20:849-857.
15. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189:847-850.
16. Langer KJ, Braun U, Kops ER, et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinoma. J Nucl Med 1993; 34:355-359.
17. Mackall CL, Fleisher TA, Brown MR, et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994; 84:2221-2228.
18. Mackall CL, Fleisher TA, Brown MR, et al. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997; 89:3700-3707.
19. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332:143-149.
20. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-dluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissue studied by microautoradiology. J Nucl Med 1992; 33:1972-1980.
21. Abbas AK, Lichtman AH. Cellular and molecular immunology, 5th edn. Philadelphia: Saunders, 2003.
22. Donahue DM, Leonard JC, Basmadjian GP, et al. Thymic gallium-67 localization in pediatric patients on chemotherapy: concise communication. J Nucl Med 1981; 22:1043-1048.